1201787-97-4

Upstream product

• 1201788-02-4 C₁₆H₁₃ClN₄O 
• 1201788-03-5 C₂₁H₂₁ClN₄O₃ 
• 1201787-99-6 3-methoxy-4-iodo-6-pyrid-3-yl-9-(toluene-4-sulfonyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine 
• 1201787-98-5 3-methoxy-6-pyrid-3-yl-9-(toluene-4-sulfonyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine 
• 1201786-89-1 3-methoxy-6-(pyrid-3-yl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine 
• 3134-35-8 2-(3'-pyridyl)-5-chloropyridine 
• 329214-79-1 3-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine 
• 616880-14-9 N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanesulfonamide 
• 1201788-00-2 3-methoxy-4-iodo-6-(pyrid-3-yl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine 
• 16110-09-1 2,5 dichloropyridine 

Relevant academic research and scientific papers

AZACARBOLINE DERIVATIVES, PREPARATION METHOD THEREOF AND THERAPEUTIC USE OF SAME

The invention relates to novel azacarbonlines having formula (I), wherein: R3, R4 represent independently H; hal; CF3; substituted oxy, optionally substituted alkoxy; optionally substituted amino; substituted carbonyl; optionally substituted carboxyl; optionally substituted amide; sulphur, such as optionally substituted sulphones, sulphoxides or sulphides; linear, branched or cyclic C1-C10 alkyl optionally comprising an optionally substituted heteroatom; optionally substituted linear, branched or cyclic C2-C7 alkenyl; optionally substituted linear or branched C2-C6 alkynyl; optionally substituted aryl or heteroaryl; of which may be optionally substituted; in the form of a base or an acid addition salt. The invention also relates to the use of same in therapeutics for the treatment of cancer and to synthesis methods.